PainReform Ltd. (PRFX)

USD 1.75

(-7.0%)

Long Term Debt Summary of PainReform Ltd.

  • PainReform Ltd.'s latest annual long term debt in 2023 was 30 Thousand USD , down 0.0% from previous year.
  • PainReform Ltd.'s latest quarterly long term debt in 2024 Q2 was 2000.00 USD , down 0.0% from previous quarter.
  • PainReform Ltd. reported annual long term debt of - USD in 2022, down 0.0% from previous year.
  • PainReform Ltd. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • PainReform Ltd. reported quarterly long term debt of 15 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • PainReform Ltd. reported quarterly long term debt of 30 Thousand USD for 2023 Q4, down -23.08% from previous quarter.

Annual Long Term Debt Chart of PainReform Ltd. (2023 - 2017)

Historical Annual Long Term Debt of PainReform Ltd. (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 30 Thousand USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD -100.0%
2018 4.52 Million USD 21.9%
2017 3.7 Million USD 0.0%

Peer Long Term Debt Comparison of PainReform Ltd.

Name Long Term Debt Long Term Debt Difference
Journey Medical Corporation 14.62 Million USD 99.795%
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.99%
Aquestive Therapeutics, Inc. 91.07 Million USD 99.967%
Pacira BioSciences, Inc. 513.79 Million USD 99.994%
Sunshine Biopharma, Inc. 539.03 Thousand USD 94.434%
Sunshine Biopharma, Inc. 539.03 Thousand USD 94.434%
SCYNEXIS, Inc. 12.15 Million USD 99.753%
Safety Shot Inc 304.9 Thousand USD 90.161%
Alpha Teknova, Inc. 13.25 Million USD 99.774%
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.994%
Bright Green Corporation 201.78 Thousand USD 85.133%
Dynavax Technologies Corporation 252.41 Million USD 99.988%
Esperion Therapeutics, Inc. 501.54 Million USD 99.994%
Cosmos Health Inc. 3.03 Million USD 99.012%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD 74.387%
Embecta Corp. 1.62 Billion USD 99.998%
Intra-Cellular Therapies, Inc. 13.32 Million USD 99.775%
Procaps Group, S.A. 28.41 Million USD 99.894%
Theratechnologies Inc. 51.26 Million USD 99.941%
Harrow Health, Inc. 183.17 Million USD 99.984%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD 65.517%
Biofrontera Inc. 804 Thousand USD 96.269%
DURECT Corporation 2.7 Million USD 98.89%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 99.91%
Cronos Group Inc. 1.55 Million USD 98.076%
OptiNose, Inc. 611 Thousand USD 95.09%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.994%
Kala Pharmaceuticals, Inc. 34.19 Million USD 99.912%
RedHill Biopharma Ltd. 455 Thousand USD 93.407%
Organogenesis Holdings Inc. 60.74 Million USD 99.951%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 99.765%
Radius Health, Inc. 339.66 Million USD 99.991%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD 99.708%
Phibro Animal Health Corporation 458.28 Million USD 99.993%
Procaps Group S.A. 28.41 Million USD 99.894%
Alvotech 1.02 Billion USD 99.997%
TherapeuticsMD, Inc. 6.53 Million USD 99.541%
Viatris Inc. 16.18 Billion USD 100.0%
Rockwell Medical, Inc. 8.29 Million USD 99.638%
Aytu BioPharma, Inc. 10.87 Million USD 99.724%
SIGA Technologies, Inc. 335.99 Thousand USD 91.071%
Tilray Brands, Inc. 287.93 Million USD 99.99%
Lifecore Biomedical, Inc. 120.51 Million USD 99.975%
Shineco, Inc. 10.01 Million USD 99.701%
PetIQ, Inc. 437.82 Million USD 99.993%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 210 Thousand USD 85.714%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.988%
Alimera Sciences, Inc. 64.48 Million USD 99.953%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 38.51 Million USD 99.922%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD 77.792%
Petros Pharmaceuticals, Inc. 6.85 Million USD 99.563%
Clever Leaves Holdings Inc. 720 Thousand USD 95.833%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -33.428%
Avadel Pharmaceuticals plc 32.75 Million USD 99.908%
Hempacco Co., Inc. 5.93 Million USD 99.494%
Talphera, Inc. - USD -Infinity%
Alvotech 1.02 Billion USD 99.997%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 99.947%
Lantheus Holdings, Inc. 616.12 Million USD 99.995%
Currenc Group, Inc. 2.5 Million USD 98.803%
Kamada Ltd. 7.43 Million USD 99.597%
Indivior PLC 235.66 Million USD 99.987%
Evoke Pharma, Inc. 5 Million USD 99.4%
Flora Growth Corp. 942 Thousand USD 96.815%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -33.428%
Evolus, Inc. 120.35 Million USD 99.975%
HUTCHMED (China) Limited 48.18 Million USD 99.938%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.995%
Akanda Corp. 2.49 Million USD 98.799%